Cargando…

PHOSPHO1 Serves as a Key Metabolism-Related Biomarker in the Tumorigenesis of Diffuse Large B-cell Lymphoma

OBJECTIVE: Diffuse large B-cell lymphoma (DLBCL) is an aggressive type of non-Hodgkin lymphoma. Due to its genetic heterogeneity and abnormal metabolism, many DLBCL patients have a poor prognosis. This study investigated the key metabolism-related genes and potential mechanisms. METHODS: Differentia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Tian-rui, Cao, Huang-ming, Wu, Yin, Xie, Jiang-tao, Lan, Hai-feng, Jin, Li-na
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Huazhong University of Science and Technology 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362366/ https://www.ncbi.nlm.nih.gov/pubmed/35943680 http://dx.doi.org/10.1007/s11596-022-2612-6

Ejemplares similares

Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis
por: Bilajac, Esma, et al.
Publicado: (2022)

Diffuse large B‐cell lymphoma in large intestine presenting as multiple polypoid lesions
por: Yang, Rui, et al.
Publicado: (2023)

Increased histone deacetylase 6 expression serves as a favorable prognostic factor for diffuse large B-cell lymphoma
por: Lin, Xiao-Ji, et al.
Publicado: (2017)

Upregulated GRB7 promotes proliferation and tumorigenesis of Bladder Cancer via Phospho-AKT Pathway
por: Zheng, Yingchun, et al.
Publicado: (2020)

STAT3 Targets Suggest Mechanisms of Aggressive Tumorigenesis in Diffuse Large B-Cell Lymphoma
por: Hardee, Jennifer, et al.
Publicado: (2013)

Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma
por: Zhou, Xiangxiang, et al.
Publicado: (2020)

Identification of key snoRNAs serves as biomarkers for hepatocellular carcinoma by bioinformatics methods
por: Xie, Qingqing, et al.
Publicado: (2022)

Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling
por: Yang, Juan, et al.
Publicado: (2020)

Serine Protease 3 Promotes Progression of Diffuse Large B-Cell Lymphoma and Serves as a Novel Prognostic Predictor
por: Zheng, Liangda, et al.
Publicado: (2022)

Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target
por: Xie, Ping, et al.
Publicado: (2017)

Long Noncoding RNA SNHG12 Indicates the Prognosis and Accelerates Tumorigenesis of Diffuse Large B-Cell Lymphoma Through Sponging microR-195
por: Chen, Li-Yan, et al.
Publicado: (2020)

CCDC50, an essential driver involved in tumorigenesis, is a potential severity marker of diffuse large B cell lymphoma
por: Gong, Yuqi, et al.
Publicado: (2023)

Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023)

The Prognostic Value of Blood-Based Biomarkers in Patients With Testicular Diffuse Large B-Cell Lymphoma
por: Yang, Jing, et al.
Publicado: (2019)

Circulating exosomal microRNAs as diagnostic and prognostic biomarkers in patients with diffuse large B‐cell lymphoma
por: Cao, Di, et al.
Publicado: (2021)

Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma
por: Yin, Chengliang, et al.
Publicado: (2020)

Primary breast diffuse large B-cell lymphoma in the era of rituximab
por: Zhang, Na, et al.
Publicado: (2016)

Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma
por: Hammouda, Nada E., et al.
Publicado: (2017)

A phospho-switch controls RNF43-mediated degradation of Wnt receptors to suppress tumorigenesis
por: Tsukiyama, Tadasuke, et al.
Publicado: (2020)

Primary breast diffuse large B cell lymphoma
por: Guo, Mengni, et al.
Publicado: (2022)

Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023)

Can Diffusion-Weighted Imaging Serve as an Imaging Biomarker for Acute Bacterial Rhinosinusitis?
por: Bhatt, Alok A, et al.
Publicado: (2020)

Immune targeted therapy for diffuse large B cell lymphoma
por: Zheng, Yaxin, et al.
Publicado: (2021)

Overexpression of sphingosine-1-phosphate receptor 1 and phospho-signal transducer and activator of transcription 3 is associated with poor prognosis in rituximab-treated diffuse large B-cell lymphomas
por: Paik, Jin Ho, et al.
Publicado: (2014)

Primary testicular diffuse large B-cell lymphoma: Case series
por: Wang, Qi, et al.
Publicado: (2020)

DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma
por: Ferraresso, Serena, et al.
Publicado: (2017)

Circulating Exosomal MiR-107 Restrains Tumorigenesis in Diffuse Large B-Cell Lymphoma by Targeting 14-3-3η
por: Liu, Jiarui, et al.
Publicado: (2021)

Circulating RNA biomarkers in diffuse large B-cell lymphoma: a systematic review
por: Decruyenaere, Philippe, et al.
Publicado: (2021)

Rapid identification of novel independent serum biomarkers in diffuse large B-cell lymphoma
por: Che, Yi-Qun, et al.
Publicado: (2020)

Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma
por: Liang, Xiao-jie, et al.
Publicado: (2022)

Capable Infection of Hepatitis B Virus in Diffuse Large B-cell Lymphoma
por: Wang, Yanchun, et al.
Publicado: (2018)

Metadherin Contributes to the Pathogenesis of Diffuse Large B-cell Lymphoma
por: Ge, Xueling, et al.
Publicado: (2012)

Aberrant methylation in neurofunctional gene serves as a hallmark of tumorigenesis and progression in colorectal cancer
por: Li, Xuan, et al.
Publicado: (2023)

Apatinib enhances chemosensitivity of ABT‐199 in diffuse large B‐cell lymphoma
por: Shi, Yuanfei, et al.
Publicado: (2022)

An Immune-Related Prognostic Classifier Is Associated with Diffuse Large B Cell Lymphoma Microenvironment
por: Liang, Xiao-Jie, et al.
Publicado: (2021)

Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation
por: Hodkinson, Brendan P., et al.
Publicado: (2020)

Correlation Between C-MYC, BCL-2, and BCL-6 Protein Expression and Gene Translocation as Biomarkers in Diagnosis and Prognosis of Diffuse Large B-cell Lymphoma
por: Zhang, YunXiang, et al.
Publicado: (2019)

The new German evidence-based guideline on diffuse large B-cell lymphoma—key aspects for radiation oncologists
por: Oertel, Michael, et al.
Publicado: (2023)

Prognostic Biomarkers and EBV Infection Research in Diffuse Large B-Cell Lymphoma of the Palatine Tonsils
por: Marques, Marinho, et al.
Publicado: (2012)

Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: a systematic review
por: Lopez-Santillan, Maria, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d1adisu1c9n2qfsa4voisvo4h4